Related by context. Frequent words. (Click for all words.) 55 www.pvh.com 54 www.ahtreit.com 52 http:/www.omtr.com 51 www.targacept.com 51 www.kilroyrealty.com 50 www.hcpi.com 50 www.microtune.com 50 http:/www.sonoco.com/ 49 isavailable 49 www.ciena.com 49 pressrelease 48 www.tri valleycorp.com 48 www.adept.com 48 http:/www.pinksheets.com 48 www.monsterworldwide.com 48 www.spec.org 47 www.diodes.com 47 www.wipro.com 47 www.amedisys.com 47 www.aezsinc.com 47 www.methylgene.com 46 www.essexpropertytrust.com 45 http:/www.nice.com 44 www.idc.com 44 http:/www.ap-gfkpoll.com 44 PreGen Plus 44 visit www.infosys.com 44 http:/surveys.ap.org 43 tables summarize 43 www.ocztechnology.com 43 Market Commentary 43 www.nanomarkets.net 43 unaudited consolidated interim 43 www.ipsen.com 43 www.mcfco.com 43 Funding Announcement 43 within themeaning 42 #QSB 42 pro forma adjusted EBITDA 42 Caution Concerning Forward Looking 42 quarterly 42 http:/www.diodes.com 42 normalized FFO 42 Form# K 42 www.slgreen.com 42 PRWeb disclaims any 41 visit www.marriott.com 41 www.allos.com 41 Safe Harbor Statements 41 website www.chinacrescent.com 41 theforward looking 41 condensed consolidated balance sheets 41 Monthly Volume 41 AM Eastern Daylight 41 seat mile RASM 41 Statements Certain 40 http:/www.emailwire.com 40 NASDAQ SLXP today 40 inclusive 40 follows > 40 #Q filing 40 concerning Alnylam 39 Q2 FY# [001] 39 Cautionary Notice 39 Appendix 4D 39 Cricket PAYGo 39 Preliminary Assessment Study 39 SaaS Showplace 39 www.fuelcellenergy.com 39 outturns 39 results 39 see www.fujitsu.com 39 Cautionary Statements 39 interim unaudited consolidated 39 SS NOI 39 suchforward looking 39 Visit www.chelseapies.tv 39 -Cullercoats 39 Corp. TSX LSG 38 forward.looking statements 38 NYSE GIL 38 Visit www.manunitedpies.tv 38 Visit www.TechDigest.tv 38 Domain Name Industry 38 Analyst Briefing 38 through WebWire R 38 FINANCIAL CONDITION AND 38 NCCN Guidelines 38 SchaeffersResearch.com 38 audited consolidated 37 Visit www.availableforpanto.com 37 subsequently archived webcast 37 Quarter Fiscal 37 cabozantinib 37 Semiannual 37 2nd Quarter Results 37 www.s1.com 37 www.infineon.com 36 Cautionary Statement 36 www.syntelinc.com 36 Significant assay